|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.53 EUR | -3.15% |
|
-1.20% | -10.01% |
| 12-13 | After years of crisis: Chemicals industry expects mini-growth in 2025 | DP |
| 12-12 | LANXESS : 2024 trend shows an improvement |  |
| Capitalization | 2.2B 2.31B 2.07B 1.83B 3.29B 196B 3.64B 25.42B 9.4B 80.87B 8.69B 8.5B 356B | P/E ratio 2024 * |
-12x | P/E ratio 2025 * | -626x |
|---|---|---|---|---|---|
| Enterprise value | 4.68B 4.92B 4.39B 3.9B 7B 417B 7.74B 54.01B 19.98B 172B 18.48B 18.06B 756B | EV / Sales 2024 * |
0.73x | EV / Sales 2025 * | 0.64x |
| Free-Float |
94.86% | Yield 2024 * |
0.48% | Yield 2025 * | 1.81% |
More valuation ratios
* Estimated data
More news
Last Transcript: LANXESS AG
More press releases
More news
| 1 day | -3.15% | ||
| 1 week | -1.20% | ||
| Current month | +7.90% | ||
| 1 month | +13.06% | ||
| 3 months | +0.59% | ||
| 6 months | +15.78% | ||
| Current year | -10.01% |
1 week
25.50
26.78
1 month
22.8326.78
Current year
21.0029.80
1 year
21.0029.80
3 years
20.1459.04
5 years
20.1467.38
10 years
20.1474.78
| Director | Title | Age | Since |
|---|---|---|---|
Matthias Zachert
CEO | Chief Executive Officer | 57 | 2014-03-31 |
Oliver Stratmann
DFI | Director of Finance/CFO | 52 | 2023-08-31 |
Eva Frerker
IRC | Investor Relations Contact | - | 2022-10-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 2024-05-23 | |
| Director/Board Member | 65 | 2013-12-31 | |
Lawrence Rosen
BRD | Director/Board Member | 67 | 2015-05-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.09% | 17 M€ | -.--% | - | |
| 1.82% | 202 M€ | -.--% | ||
| 0.32% | 2 M€ | +13.56% | - | |
| 0.15% | 20 M€ | +16.38% | - | |
| 0.14% | 79 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -3.15% | -1.20% | -5.44% | -50.68% | 2.31B | ||
| -2.86% | -4.19% | +5.30% | +32.92% | 67.83B | ||
| -1.02% | +1.46% | -6.30% | -25.12% | 41.79B | ||
| -0.88% | -2.39% | +12.45% | +4.13% | 33.79B | ||
| -0.15% | +0.73% | +21.42% | +35.07% | 19.1B | ||
| -1.24% | -2.54% | +13.00% | -14.20% | 11.41B | ||
| -1.15% | -1.55% | +5.23% | -1.82% | 9.72B | ||
| -0.81% | -0.33% | -23.82% | -20.90% | 9.26B | ||
| -2.81% | +0.36% | -25.78% | - | 8.28B | ||
| -0.06% | +0.10% | -4.78% | +6.85% | 8.03B | ||
| Average | -1.41% | -0.96% | -0.87% | -3.75% | 21.15B | |
| Weighted average by Cap. | -1.57% | -1.59% | +3.03% | +7.66% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 6.38B 6.7B 5.99B 5.31B 9.54B 568B 10.54B 73.6B 27.22B 234B 25.17B 24.61B 1,030B | 6.6B 6.92B 6.18B 5.48B 9.86B 587B 10.89B 76.05B 28.13B 242B 26.01B 25.43B 1,064B |
| Net income | -181M -190M -170M -150M -270M -16.1B -299M -2.08B -771M -6.63B -713M -697M -29.17B | -10.68M -11.21M -10.02M -8.88M -15.96M -951M -17.64M -123M -45.55M -392M -42.13M -41.19M -1.72B |
| Net Debt | 2.48B 2.6B 2.33B 2.06B 3.71B 221B 4.1B 28.6B 10.58B 90.99B 9.78B 9.56B 400B | 2.04B 2.14B 1.91B 1.7B 3.05B 182B 3.37B 23.51B 8.69B 74.79B 8.04B 7.86B 329B |
More financial data
* Estimated data
Employees
12,849
Sector
Diversified Chemicals
Calendar
2025-03-12
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-13 | 25.53 € | -3.15% | 142,291 |
| 24-12-12 | 26.36 € | +0.92% | 201,564 |
| 24-12-11 | 26.12 € | -1.62% | 176,129 |
| 24-12-10 | 26.55 € | +0.64% | 174,742 |
| 24-12-09 | 26.38 € | +2.09% | 326,682 |
Delayed Quote Xetra, December 13, 2024 at 11:35 am
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
25.53EUR
Average target price
28.84EUR
Spread / Average Target
+12.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LXS Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition